Stock listing
THAT Stock Price, News, Filings & Events — Thalia Therapeutics Plc
Selected listing: THAT · LSE · GBX · GB
This page tracks Thalia Therapeutics Plc's THAT:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following THAT:LSE. THAT:LSE is the stock-level entry point for investors researching Thalia Therapeutics Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Thalia Therapeutics Plc, trading under the ticker THAT, is a public company listed in the UK with a market capitalization of approximately £22.99 million. The company focuses on developing innovative therapeutic solutions. Thalia Therapeutics aims to address unmet medical needs through its research and development efforts.
- Ticker
- THAT:LSE
- Asset type
- Stock
- Market cap
- $21.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- GBX
Thalia Therapeutics Plc THAT:LSE stock context
This page tracks Thalia Therapeutics Plc's THAT:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following THAT:LSE. THAT:LSE is the stock-level entry point for investors researching Thalia Therapeutics Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Thalia Therapeutics Plc, trading under the ticker THAT, is a public company listed in the UK with a market capitalization of approximately £22.99 million. The company focuses on developing innovative therapeutic solutions. Thalia Therapeutics aims to address unmet medical needs through its research and development efforts.
Latest news from Thalia Therapeutics Plc
Thalia Therapeutics Plc earnings calls
THALIA THERAPEUTICS PLC (THAT) — Investor Presentation
June 24, 2026 · Replay with transcript and chapters
THALIA THERAPEUTICS PLC (THAT) — Interim results for the six months ended 30 June 2025
September 25, 2025 · Replay with transcript and chapters
THALIA THERAPEUTICS PLC (THAT) — Investor Webinar
February 4, 2025 · Replay with transcript and chapters
Research Thalia Therapeutics Plc
Thalia Therapeutics Plc investor report
Review AI stock analysis and investor report context for THAT:LSE.
Thalia Therapeutics Plc company profile
View the public company page for Thalia Therapeutics Plc on 6ix.
Thalia Therapeutics Plc news
Read company news and market updates connected to Thalia Therapeutics Plc.
Thalia Therapeutics Plc investor events
Find investor webinars, events, and replay context for Thalia Therapeutics Plc.
Alternate listings
A2DQES:LSX
DE · EUR
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is THAT:LSE.
A2DQES:LS
DE · EUR
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is THAT:LSE.
0GO:SWB
DE · EUR
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is THAT:LSE.
THAT.GB:AQUIS
GB · GBX
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is THAT:LSE.
0GO:FWB
DE · EUR
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is THAT:LSE.